Firefly NeuroscienceAIFF -0.78%9 Return-on-Tangible-Equity is -396.34% as of Mar. 2026. GuruFocus rates AIFF with a GF Score™ of 9/100. The stock has 4 warning signs investors should review. Among 2,468 Software companies, Firefly Neuroscience ranks worse than 95.99% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Firefly Neuroscience's annualized net income for the quarter that ended in Mar. 2026 was $-8.02 Mil. Firefly Neuroscience's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $2.02 Mil. Therefore, Firefly Neuroscience's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -396.34%.
The historical rank and industry rank for Firefly Neuroscience's Return-on-Tangible-Equity or its related term are showing as below:
AIFF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -3801.53 Med: -3801.53 Max: -242.42
Current: -242.42
During the past 5 years, Firefly Neuroscience's highest Return-on-Tangible-Equity was -242.42%. The lowest was -3,801.53%. And the median was -3,801.53%.
AIFF's Return-on-Tangible-Equity is ranked worse than 95.99% of 2468
companies
in the Software industry
Industry Median: 8.605
vs AIFF: -242.42
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Firefly Neuroscience Return-on-Tangible-Equity Related Terms
Firefly Neuroscience Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Firefly Neuroscience's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIFF vs CXAI, FALC, MNDO: Return-on-Tangible-Equity Comparison
For the Software - Application subindustry, Firefly Neuroscience's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Firefly Neuroscience Return-on-Tangible-Equity vs Software Industry
For the Software industry and Technology sector, Firefly Neuroscience's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Firefly Neuroscience's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -396.34% mean?
Firefly Neuroscience (AIFF) has a Return-on-Tangible-Equity of -396.34% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Firefly Neuroscience and its competitors. According to the industry distribution chart, Firefly Neuroscience ranks #2369 out of 2468 companies in the Software industry, placing it in the top 96%.
Is Firefly Neuroscience's Return-on-Tangible-Equity too high?
Firefly Neuroscience's current Return-on-Tangible-Equity is -396.34%. Based on the distribution chart, Firefly Neuroscience ranks #2369 out of 2468 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Firefly Neuroscience has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's Return-on-Tangible-Equity compare to CXAI and FALC?
According to the Software industry distribution chart, Firefly Neuroscience ranks #2369 out of 2468 companies for Return-on-Tangible-Equity. This places Firefly Neuroscience in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Software company?
The median Return-on-Tangible-Equity among Software companies is 8.61, based on 2,468 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Firefly Neuroscience and its competitors. For the Software industry, the median Return-on-Tangible-Equity is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current Return-on-Tangible-Equity is -396.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current Return-on-Tangible-Equity of -396.34%. The current Return-on-Tangible-Equity is -396.34%. Firefly Neuroscience's overall GF Score™ is 9/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current Return-on-Tangible-Equity is -396.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
9GF Score
Get the complete analysis for AIFF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIFF has been successfully added to your 
